New Delhi, July 30, 2024: A study conducted by Tata Memorial Hospital in Mumbai has shown that adding Nimotuzumab to the standard treatment regimen significantly improves the 10-year overall survival rate for patients with locally advanced squamous cell carcinoma of the head and neck. The results of the Phase III study on 536 patients confirmed …
News Stories